Omega Walnut (Juglans regia 'Chandler')

Omega Walnut (Juglans regia 'Chandler') is a cultivated walnut variety characterized by an exceptionally high alpha-linolenic acid (ALA) content and polyphenol concentrations up to 5100 mg GAE per 100 g kernel. Its primary bioactive compounds — ALA, ellagitannins, and juglone — modulate inflammatory pathways and exert antioxidant activity through free radical scavenging.

Origin & History

Omega Walnut (Juglans regia 'Chandler') is a cultivated variety of English walnut tree originating from selective breeding programs in California and Chile, prized for its high yield and quality nuts. The nuts are harvested and consumed whole or processed into kernels, with chemical analysis involving methanol or hexane extraction for polyphenols and fatty acids. This variety belongs to the tree nut class rich in polyunsaturated fatty acids, particularly omega-6 linoleic acid (58-63%) and omega-3 alpha-linolenic acid (10.5-15%).

Historical & Cultural Context

No historical or traditional medicine uses specific to Juglans regia 'Chandler' were identified, as this is a modern cultivar. General Juglans regia walnuts have been consumed for nutrition, but documented traditional systems or durations are absent from available research.

Health Benefits

• High omega-3:omega-6 PUFA ratio may reduce inflammation (compositional data only, no clinical trials)
• Polyphenols (up to 5100 mg GAE/100 g kernel) provide antioxidant activity (in vitro evidence only)
• Cytotoxic properties may prevent free radical-induced nucleic acid damage (preliminary evidence)
• Rich in γ-tocopherol (47.5-62.2 mg/100 g) supporting antioxidant defense (compositional analysis)
• Higher mineral content (K, Cu, Zn) compared to some walnut varieties (compositional data only)

How It Works

Alpha-linolenic acid (ALA) in Omega Walnut serves as a precursor to EPA and DHA, competitively inhibiting delta-6-desaturase activity of omega-6 arachidonic acid metabolism and thereby reducing downstream synthesis of pro-inflammatory eicosanoids such as prostaglandin E2 and leukotriene B4. Ellagitannins, including pedunculagin and tellimagrandin, are metabolized by gut microbiota into urolithins, which inhibit NF-κB signaling and downregulate COX-2 expression. Juglone (5-hydroxy-1,4-naphthoquinone) acts as a reactive oxygen species scavenger and may intercalate with DNA to prevent oxidative strand breaks, as suggested by preliminary in vitro cytotoxicity assays.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on Juglans regia 'Chandler' were identified. General walnut research attributes health benefits to omega-3:omega-6 ratios and polyphenols, but lacks variety-specific human studies with PubMed PMIDs. Current research focuses solely on compositional analysis rather than clinical outcomes.

Clinical Summary

No cultivar-specific randomized controlled trials exist for Juglans regia 'Chandler'; available evidence is limited to compositional analyses and in vitro studies. Broader walnut research, such as the WAHA trial (n=708), demonstrated that daily walnut consumption (30–60 g) reduced LDL cholesterol by approximately 4.3% and inflammatory markers including IL-6, but these findings cannot be directly extrapolated to the Chandler cultivar. In vitro antioxidant assays using Chandler kernel extracts report DPPH radical scavenging activity consistent with high polyphenol load, though bioavailability in humans remains unquantified. The current evidence base warrants cautious interpretation; cultivar-specific human trials are needed to validate compositional advantages as clinical outcomes.

Nutritional Profile

Omega Walnut (Juglans regia 'Chandler') is a high-fat, moderate-protein tree nut with a distinctive fatty acid profile. Macronutrients per 100 g kernel (approximate): total fat 60–65 g, protein 14–17 g, carbohydrates 14–16 g, dietary fiber 6–7 g, moisture 3–5 g, energy ~650–700 kcal. Fatty acid profile is characterized by a notably favorable PUFA composition: α-linolenic acid (ALA, omega-3) 8–13 g/100 g, linoleic acid (omega-6) 33–38 g/100 g, oleic acid (omega-9, MUFA) 9–12 g/100 g, saturated fatty acids (primarily palmitic and stearic) 6–8 g/100 g; the omega-6:omega-3 ratio in 'Chandler' is reported at approximately 4:1–5:1, comparatively lower than many other walnut cultivars. Vitamin E: dominated by γ-tocopherol at 47.5–62.2 mg/100 g (exceptionally high relative to most tree nuts), with α-tocopherol present at 1.5–3.0 mg/100 g; total tocopherol content supports lipid-phase antioxidant defense. B vitamins include folate (~98 µg/100 g DFE), B6 (~0.54 mg/100 g), thiamine (~0.34 mg/100 g), and riboflavin (~0.15 mg/100 g). Minerals: magnesium 155–175 mg/100 g, phosphorus 340–360 mg/100 g, potassium 440–470 mg/100 g, copper 1.5–1.8 mg/100 g, manganese 3.0–3.5 mg/100 g, zinc 2.5–3.5 mg/100 g, calcium 95–110 mg/100 g, iron 2.6–3.0 mg/100 g, selenium 4–5 µg/100 g. Polyphenol content: total polyphenols up to 5100 mg GAE/100 g kernel (skin-inclusive), with ellagitannins (pedunculagin, tellimagrandin), juglone precursors, flavonoids (quercetin, kaempferol glycosides), and phenolic acids (chlorogenic, gallic, ellagic) as primary contributors; skin removal significantly reduces polyphenol content. Phytosterols: ~113–115 mg/100 g, predominantly β-sitosterol. Melatonin reported at ~3.5 ng/g kernel. Bioavailability notes: ALA bioconversion to EPA/DHA is limited in humans (estimated <5–15%); polyphenol bioavailability is matrix-dependent and relatively low for ellagitannins (converted to urolithins by gut microbiota with high inter-individual variability); mineral absorption is partially inhibited by phytic acid content (~760 mg/100 g); γ-tocopherol has lower bioavailability than α-tocopherol due to preferential hepatic retention of α-form, though absolute tissue delivery remains meaningful given high concentrations.

Preparation & Dosage

No clinically studied dosage ranges for 'Chandler' walnuts or standardized forms exist. Compositional data shows total phenolic content at approximately 5100 mg GAE/100 g in kernels. No standardization or clinical dosing guidelines available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin E, Fish Oil, Flaxseed Oil, Alpha-Lipoic Acid, Selenium

Safety & Interactions

Omega Walnut is generally regarded as safe when consumed in typical dietary amounts (28–60 g/day), but tree nut allergy is a significant contraindication, with IgE-mediated reactions ranging from oral allergy syndrome to anaphylaxis. Juglone content may theoretically inhibit CYP450 enzymes, raising concern for interactions with warfarin, statins, and immunosuppressants, though clinical pharmacokinetic data specific to this cultivar are absent. The high ALA content may have additive anticoagulant effects when combined with antiplatelet drugs such as aspirin or clopidogrel. Pregnancy safety at dietary intake levels is considered acceptable, but supplemental or concentrated extract doses lack sufficient safety data for pregnant or lactating individuals.